Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
July 25, 2025
Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome-insights from a UK center
Giulia Simini, Andrew Innes, Saravanan Vinayagam, et al.
British Journal of Haematology
|
January 8, 2022
Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?
Katherine M Dominy, Simone Claudiani, Matthew O'Hare, et al.
Haematologica
|
May 13, 2017
E14a2 <i>BCR-ABL1</i> transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy
Simone Claudiani, Jane F Apperley, Robert Peter Gale, et al.
Bone Marrow Transplantation
|
April 4, 2023
The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
Fiona Fernando, Andrew J Innes, Simone Claudiani, et al.
Leukemia & Lymphoma
|
April 23, 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr, Simone Claudiani, Dragana Milojkovic, et al.
Leukemia
|
February 29, 2024
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance
Simone Claudiani, Farhan Chughtai, Afzal Khan, et al.
Journal of Clinical Pathology
|
April 21, 2019
T-cell prolymphocytic leukaemia in a patient with chronic myeloid leukaemia receiving nilotinib: first documented report
Brian Hanley, George Nesr, Eva Yebra-Fernandez, et al.
BMC Medical Genomics
|
July 26, 2023
FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
Philippa C May, Alistair G Reid, Mark E Robinson, et al.
Haematologica
|
March 30, 2019
MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia
Simone Claudiani, Aoife Gatenby, Richard Szydlo, et al.
British Journal of Haematology
|
December 19, 2021
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors
Simone Claudiani, Jane F Apperley, Eleanor L Parker, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Research and Practice in Thrombosis and Haemostasis
|
July 25, 2025
Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome-insights from a UK center
Giulia Simini, Andrew Innes, Saravanan Vinayagam, et al.
British Journal of Haematology
|
January 8, 2022
Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?
Katherine M Dominy, Simone Claudiani, Matthew O'Hare, et al.
Haematologica
|
May 13, 2017
E14a2 <i>BCR-ABL1</i> transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy
Simone Claudiani, Jane F Apperley, Robert Peter Gale, et al.
Bone Marrow Transplantation
|
April 4, 2023
The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
Fiona Fernando, Andrew J Innes, Simone Claudiani, et al.
Leukemia & Lymphoma
|
April 23, 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr, Simone Claudiani, Dragana Milojkovic, et al.
Leukemia
|
February 29, 2024
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance
Simone Claudiani, Farhan Chughtai, Afzal Khan, et al.
Journal of Clinical Pathology
|
April 21, 2019
T-cell prolymphocytic leukaemia in a patient with chronic myeloid leukaemia receiving nilotinib: first documented report
Brian Hanley, George Nesr, Eva Yebra-Fernandez, et al.
BMC Medical Genomics
|
July 26, 2023
FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
Philippa C May, Alistair G Reid, Mark E Robinson, et al.
Haematologica
|
March 30, 2019
MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia
Simone Claudiani, Aoife Gatenby, Richard Szydlo, et al.
British Journal of Haematology
|
December 19, 2021
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors
Simone Claudiani, Jane F Apperley, Eleanor L Parker, et al.
Page
of 4